A Place for psychostimulants in palliative care?

Journal of Palliative Care

Volumn 18, Issue 3, 2002, Pages 196-199

  Dein, Simon ^a   George, Rob ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ARTICLE; DEPRESSION; FATIGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PAIN; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT;

CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; FATIGUE; HIV INFECTIONS; HUMANS; PAIN; PALLIATIVE CARE;

EID: 0036730548     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585970201800309     Document Type: Review

References (27)

1. Masand PS, Tesar GE. Use of stimulants in the medically ill. Psychiatric Clin North Am 1996; 19: 515-547.
2. Homsi J, Walsh D, Nelson K. Psychostimulants in supportive care. Support Care Cancer 2000; 8: 385-397.
3. Frierson RL, Wey JJ, Tabler JB. Psychostimulants for depression in the medically ill. Am Fam Physician 1991; 43: 163-170.
4. Dein S. The use of psychostimulants by palliative care consultants in the UK: a retrospective telephone survey. Palliat Med [in press].
5. Fernandez F, Adams F , Holmes VF, Levy JK, Neidhart M. Methylphenidate for depressive disorders in cancer patients. Psychosomatics.1987; 28: 455-461.
6. Stiebel V, Kemp K. Long-term methylphenidate use in the medically ill patient with organic mood syndrome. Psychosomatics 1990; 31: 454-456.
7. Breitbart W, Mermelstein H. Pemoline: an alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics 1992; 33: 352-356.
8. Burns M, Eisendrath S. Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics 1994; 35(1): 80-82.
9. Olin J, Masand PS. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 1996; 37: 57-62.
10. Macleod A. Methylphenidate in terminal depression. J Pain Symptom Manage 1998; 16: 193-198.
11. Holmes VF, Fernandez F, Levy JK. Psychostimulant response in AIDS related complex patients. J Clin Psychiatry 1989 50: 5-8.
12. Fernandez F, Levy JK. Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection. Psychiatr Med 1991; 9: 377-394.
13. Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double blind placebo-controlled trial. J Clin Psychiatry 2000 61: 436-440.
14. White JC, Christensen JF, Singer CM. Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial. J Clin Psychiatry 1992; 53: 153-156.
15. Angrist B, d'Hollosy M, Sanfilipo M, Satriano J, Diamond G, Simberkoff M, Weinreb H. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol 1992; 12: 268-272.
16. Breitbart W, Passik S. Psychological and psychiatric interventions in pain control. In: Doyle D, Hanks GWC, MacDonald N (eds). Oxford Textbook of Palliative Medicine. New York: Oxford University Press, 1993; p. 253.
17. Bruera E, Miller M, Macmillan K, Kuehn N. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992 48:163-166.
18. Stiefel F, Bruera E. Psychostimulants for hypoactive hypoalert delirium? J Palliat Care 1991; 3: 25-26.
19. Monta T, Otani H, Tsumoda J. Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer 2000; 8: 134-137.
20. Bruera E, Chadwick S, et al. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 1987; 71: 67-70.
21. Kreeger L, Duncan A, Cowap J. Psychostimulants used for opioid induced drowsiness [letter]. J Pain Symptom Manage 1996; 11: 1-2.
22. Wilwerding M, Loprinzi C, Mailliard J, O'Fallon JR, Miser AW, van Haelst C, et al. A randomized crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 1995; 3: 135-138.
23. Sarhill N, Walsh D, Nelson K, Homsi J, Le Grand S, Davis MP. Methylphenidate for fatigue in advanced cancer, a prospective open-label pilot study . Am J Hosp Palliat Care 2001; 18(3): 187-192.
24. Meyers C, Weltzmer M, Valentine A, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumour patients. J Clin Oncol 1998; 16: 2522-2527.
25. Bruera E, Fainsinger R, MacEachern T, Hanson J. The use of methylphenidate in patients with incident cancer pain receiving regular opiates: a preliminary report. Pain 1992; 50: 75-77.
26. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991; 32: 203-208.
27. Krupp L, Coyle P, Doscher C, Miller A, Cross AH, Jandorf L, et al. Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantidine, pemoline, and placebo. Neurology 1995; 45(11): 1956-1961.